Progressive Therapeutics

Progressive Therapeutics in Framingham, Massachusetts offers Spravato (esketamine), the first nasal spray approved by the FDA specifically for adults with treatment-resistant depression. This fast-acting prescription treatment helps many clients feel relief within hours, offering a new option when traditional antidepressants have not worked.

Patients begin with an initial evaluation with a clinician before being admitted to the Spravato program and receiving treatment. The practice specializes in comprehensive psychiatric care with a focus on individualized treatment in a compassionate, understanding environment.

Alongside Spravato, Progressive Therapeutics offers counseling, medication management, and other innovative therapies. The practice accepts a range of insurance for Spravato treatment, including Blue Cross Blue Shield, Optum, United Healthcare, Point32Health, Harvard Pilgrim, Tufts, and Medicare.